AstraZeneca's Breztri Shows Significant Improvement in Uncontrolled Asthma Patients
Feb 13, 2026
Phase III KALOS and LOGOS trial results published in The Lancet Respiratory Medicine show Breztri Aerosphere improved lung function and reduced severe asthma exacerbations compared to dual-combination therapies in patients with uncontrolled asthma.